Soon after a half-million dollar fundraising round, EnsoData is bringing on a “dream team” of consultants to help its sleep apnea diagnosis tool get federal approval. The round, announced yesterday and led by HealthX Ventures, will help the Madison startup as it looks to submit an application with the U.S. Food and Drug Administration, said co-founder and CEO Chris Fernandez.

Read the full story here.